Libtayo plus platinum-doublet chemotherapy led to a 29% reduction in risk of death compared to chemotherapy alone

Planned Phase II study to combine the BET inhibitor with momelotinib

UK Competition and Markets Authority provisionally finds drug companies broke competition law

A group of scientists in Warsaw found a way to better control the path of light to and […]

“You hear the noises, but they don’t bother you at all”: Since 2019, the “Pengunaut Trainer” has been […]

To host big sporting events such as the Olympic Games and the Fédération Internationale de Football Association (FIFA) […]

Updated Date: Thu, 29 Jul 2021 00:00:00 EDT

An NHS boss who wrongly assured the General Medical Council that a doctor he was reporting to the […]

Sanofi, Regeneron stop Libtayo-chemo lung cancer trial early on strong survival data fkansteiner Thu, 08/05/2021 – 11:36

Moderna, citing variants and waning immunity, expects COVID-19 boosters to become a fact of life esagonowsky Thu, 08/05/2021 […]